TP53 and neoplasm: Recently, a study by Martins et al. on the recombination of TP53 in established tumors in mice have shown that TP53 is a highly potent inhibitor of tumor growth without causing further toxicity, which supports the activation of TP53 expression as a cancer treatment strategy [8].